You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity

 

Online download statistics by month:

Online download statistics by month: March 2020 to March 2026

AbstractFullPdf
Mar 2020347347184
Apr 2020323323178
May 202018318362
Jun 2020969661
Jul 2020676737
Aug 2020646449
Sep 202010910962
Oct 202012412453
Nov 2020767644
Dec 2020787834
Jan 20217576117
Feb 2021787863
Mar 202110910953
Apr 2021636343
May 2021838352
Jun 2021878755
Jul 2021767647
Aug 2021444440
Sep 2021646437
Oct 2021737350
Nov 2021444447
Dec 2021363622
Jan 2022879645
Feb 2022414237
Mar 2022667131
Apr 2022565820
May 202210311058
Jun 2022585831
Jul 2022545530
Aug 2022505228
Sep 2022727751
Oct 2022646435
Nov 2022495430
Dec 2022434314
Jan 2023818136
Feb 202310010228
Mar 202310210638
Apr 2023535420
May 2023505028
Jun 2023464724
Jul 2023444516
Aug 2023626314
Sep 2023515124
Oct 202399999
Nov 202321721727
Dec 2023656527
Jan 2024313215
Feb 2024747430
Mar 2024104105116
Apr 2024525436
May 2024505136
Jun 2024494824
Jul 2024525424
Aug 2024504819
Sep 20244242574
Oct 20244444279
Nov 2024535523
Dec 2024656624
Jan 2025494926
Feb 202510110132
Mar 2025656527
Apr 2025797937
May 2025575824
Jun 2025424218
Jul 2025110
Mar 2026220
Total507451303455